Literature DB >> 9254715

Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity.

H F Rosenberg1, K D Dyer.   

Abstract

The human eosinophil-derived neurotoxin (hEDN) is a secretory effector protein from eosinophilic leukocytes that is a member of the ribonuclease A (RNase A) family of ribonucleases. EDN is a rapidly evolving protein, accumulating non-silent mutations at a rate exceeding those of most other functional coding sequences studied in primates. Although all primate EDNs retain the structural and functional residues known to be prerequisites for ribonuclease activity, we have shown previously that recombinant EDN derived from a New World monkey sequence ( Saguinus oedipus ) had significantly less catalytic activity than the human (hEDN) ortholog.In this work, we have prepared recombinant proteins from EDN from sequences derived from orangutan (Pongo pygmaeus, oEDN) and Old World monkey (Macaca fascicularis, mcEDN) genomic DNAs, and from a second New World monkey sequence (Aotus trivirgatus, omEDN) as well. The catalytic efficiencies [ k cat/ K m (M-1s-1)] determined for both oEDN and mcEDN were similar to that determined previously for hEDN, while omEDN displayed approximately 100-fold less catalytic activity. The relative ribonuclease activities of hEDN/omEDN chimeras pointed to a C-terminal segment as crucial to the enhanced catalytic activity hEDN, and substitution of Arg 132-Ile 133 of hEDN with the Thr-Thr pair at the analogous position in omEDN resulted in an approximately 10-fold reduction in hEDN's catalytic efficiency. However, the reverse substitution, Arg-Ile for Thr-Thr in omEDN, did not enhance the catalytic efficiency of this relatively inactive protein. These results indicate that the Arg and/or Ile residues adjacent to the C-terminus are necessary (but not sufficient) for enhanced ribonuclease activity among the primate EDNs, and will permit prediction of the relative ribonuclease activities based on differences in primary structure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254715      PMCID: PMC146920          DOI: 10.1093/nar/25.17.3532

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Characteristic ribonucleolytic activity of human angiogenin.

Authors:  R Shapiro; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

Review 2.  Presence of a basic amino acid residue at either position 66 or 122 is a condition for enzymic activity in the ribonuclease superfamily.

Authors:  J J Beintema
Journal:  FEBS Lett       Date:  1989-08-28       Impact factor: 4.124

3.  Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family.

Authors:  H F Rosenberg; D G Tenen; S J Ackerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity.

Authors:  S Sorrentino; D G Glitz; K J Hamann; D A Loegering; J L Checkel; G J Gleich
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

5.  Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.

Authors:  N R Slifman; D A Loegering; D J McKean; G J Gleich
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

6.  Toxicity of an antitumor ribonuclease to Purkinje neurons.

Authors:  D L Newton; S Walbridge; S M Mikulski; W Ardelt; K Shogen; S J Ackerman; S M Rybak; R J Youle
Journal:  J Neurosci       Date:  1994-02       Impact factor: 6.167

7.  Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.

Authors:  D K St Clair; S M Rybak; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity.

Authors:  H F Rosenberg
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

Review 9.  Structure and function of ribonuclease A binding subsites.

Authors:  X Parés; M V Nogués; R de Llorens; C M Cuchillo
Journal:  Essays Biochem       Date:  1991       Impact factor: 8.000

10.  Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.

Authors:  R L Barker; D A Loegering; R M Ten; K J Hamann; L R Pease; G J Gleich
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

View more
  5 in total

1.  Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection.

Authors:  J Zhang; K D Dyer; H F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Complementary advantageous substitutions in the evolution of an antiviral RNase of higher primates.

Authors:  Jianzhi Zhang; Helene F Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 3.  Eosinophils, ribonucleases and host defense: solving the puzzle.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 4.  Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense.

Authors:  Helene F Rosenberg
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

5.  Selective cleavage of ncRNA and antiviral activity by RNase2/EDN in THP1-induced macrophages.

Authors:  Lu Lu; Jiarui Li; Ranlei Wei; Irene Guidi; Luca Cozzuto; Julia Ponomarenko; Guillem Prats-Ejarque; Ester Boix
Journal:  Cell Mol Life Sci       Date:  2022-03-26       Impact factor: 9.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.